Location: Lisbon, Portugal
We are delighted to be attending, sponsoring and presenting at the RAPS Euro Convergence from 5-8 April in Lisbon.
Purdie Pascoe’s Post Market Survey experts Marcus Torr (Head of Post Market Surveys) Ellie Baker (Commercial Director) Alice Robertson (Research Manager) and Ruby Pogson Jones (Senior Research Executive ) are exhibiting on Booth 31.
Since 2019, our dedicated team has successfully conducted 600+ surveys, collecting both high-quality (Level 4) and general usability (Level 8). Across three key areas, we ensure you collect the clinical, real-world data you need to remain proactive and compliant across global regulations:
PMCF Surveys for EU MDR
PMPF Surveys for EU IVDR
Real-World Data
Don’t miss our presentation
Real Data, Real Results: Unlocking the Power of Post-Market Surveys
Presenters: Marcus Torr & Alice Robertson
Date/Time: Wednesday, May 6, 2026, 10:15 - 10:40
With tightening global regulations and mounting pressure to demonstrate real-world performance, post-market surveys are an often-overlooked yet cost-effective solution. We'll break down global regulatory requirements (including PMCF under the EU-MDR) and beyond, showing you how to design surveys that deliver the quality and quantity of data regulators demand, backed by real-world case studies.
Learning objectives:
Identify the key global regulatory post-market data requirements, including PMCF and more, and explain how surveys can be applied as a compliant and cost-effective RWD collection method.
Design a post-market survey strategy that meets the quality and quantity standards required by regulators, applying best practice principles covered in the session.
Evaluate real-world case study examples to assess how survey-based RWD approaches have been successfully implemented, and apply relevant lessons to their own post-market surveillance programmes.
Don’t miss our presentation
How to Generate Real-World Data Through Post Market Surveys
Presented by Ruby Pogson Jones, Senior Research Executive, in the exhibition hall
Real-World Data (RWD) has become a major focus across the MedTech industry; with the evolution of regulatory expectations and the increasing global emphasis on real-world evidence (RWE). Recent regulatory developments underline this shift, including the FDA’s final guidance on the use of RWE for medical device decision-making and the European Commission’s proposal to simplify MDR and IVDR, both of which have important implications for how RWD is generated and assessed. Post Market Survey Methodologies, typically used for PMCF and PMPF data collection, generate safety & performance data and if utilised effectively, provide evidence for label expansion.
